LataMed AI Corp. (OTC: LMEDD), a healthcare technology company focused on digital health solutions in Latin America, announced it is advancing an industrial telemedicine initiative designed to bolster occupational health and emergency-response capabilities at offshore oil fields and other geographically isolated operating locations in Venezuela.
The company is developing specialized software intended to support remote medical care, incident-response coordination, and access to qualified medical guidance in areas where traditional healthcare facilities are scarce. The proposed platform will integrate with the occupational health and safety functions of participating operators, enabling authorized personnel to document incidents, initiate remote consultations, access emergency protocols, and coordinate medical support while transportation or evacuation arrangements are made.
Oil and energy operations often involve remote work sites, complex logistics, and time-sensitive health events. Management believes a dedicated telemedicine platform could help improve communication among field personnel, corporate health departments, and medical professionals during the critical period between an incident and access to in-person care. The planned system is expected to support secure communication, incident-management workflows, remote clinical guidance, and centralized reporting.
“This initiative represents a natural extension of our broader digital healthcare infrastructure strategy,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “Remote industrial operations present unique healthcare-access challenges. Our objective is to develop technology that helps occupational health teams communicate more effectively, organize critical information, and connect field personnel with qualified medical support when time and distance are significant factors.”
The industrial telemedicine initiative is expected to complement LataMed AI’s broader healthcare ecosystem, which includes its telemedicine platform and the continued development of CardioAI, PulmoAI, and NeuroAI. The company is evaluating how these technologies might ultimately support occupational health assessments, remote monitoring, clinical decision support, and preventive-care programs in industrial environments, subject to further development, testing, regulatory considerations, and commercial arrangements.
LataMed AI has not yet announced a definitive commercial agreement, deployment schedule, or revenue associated with this initiative. Additional information regarding participating operators, implementation plans, and geographic coverage will be disclosed as appropriate if and when definitive arrangements are completed.
For additional information, visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
